Contents 4 dk okuma
⚠ Important Notice
This content is for educational purposes. Individuals diagnosed with clinical depression or anxiety disorder under the supervision of a psychiatrist or clinician needs treatment. Natural supplements can complement, not replace, drug treatment. Those using antidepressants or anxiolytics should discuss drug interactions with their physicians.
Neurotransmitter Deficiency or System Disorder?
Depression is not just a lack of serotonin – this view has now been overcome. Modern neuroscience, depression decreased neuroplasticity, neuroinflammation, HPA axis dysregulation and neurotransmitter imbalance defines it as a compound disorder. Anxiety mainly involves GABA/glutamate imbalance and amygdala overactivation. This multidimensional picture necessitates approaches that target multiple systems.
Natural Supplements with High Evidence Level
Saffron (Crocus sativus)
Small short-term depression trials of saffron are promising. Finding no difference from antidepressants does not establish clinical equivalence; the clinical contribution of serotonin or GABA mechanisms in humans is unconfirmed.
St. John's wort (Hypericum perforatum)
St. John's wort: The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment.
5-HTP (5-Hydroxytryptophan)
5-HTP is a serotonin precursor. Human evidence for mood, sleep and appetite is limited; it carries a serious interaction risk with serotonergic medicines.
L-Theanine
L-Theanine: L-theanine is an amino acid found in tea. Small human studies examined stress, sleep and attention with caffeine; treatment of every anxiety condition or prevention of caffeine adverse effects has not been established.
Magnesium (Especially Glycinат / L-Threonate)
Mg L-Threonate: Magnesium L-threonate has been studied for brain magnesium and synaptic plasticity in animals. Human cognition and sleep findings are promising but limited.
Omega-3 (EPA Weighted)
Omega-3 DHA/EPA: EPA and DHA are long-chain omega-3 fatty acids; DHA is an important brain membrane component. They are not a universal supplement treatment for depression or cognitive decline; clinical results vary by population and formulation.
Which Approach in Which Situation?
| Substance | Evidence and safety |
|---|---|
| Saffron Extract: Small short-term depression trials of saffron are promising. Finding no difference from antidepressants does not establish clinical equivalence; the clinical contribution of serotonin or GABA mechanisms in humans is unconfirmed. | Small short-term depression trials of saffron are promising. Finding no difference from antidepressants does not establish clinical equivalence; the clinical contribution of serotonin or GABA mechanisms in humans is unconfirmed. |
| St. John's wort: The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment. | The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment. |
| L-Theanine: L-theanine is an amino acid found in tea. Small human studies examined stress, sleep and attention with caffeine; treatment of every anxiety condition or prevention of caffeine adverse effects has not been established. | L-theanine is an amino acid found in tea. Small human studies examined stress, sleep and attention with caffeine; treatment of every anxiety condition or prevention of caffeine adverse effects has not been established. |
| Mg L-Threonate: Magnesium L-threonate has been studied for brain magnesium and synaptic plasticity in animals. Human cognition and sleep findings are promising but limited. | Magnesium L-threonate has been studied for brain magnesium and synaptic plasticity in animals. Human cognition and sleep findings are promising but limited. |
| Omega-3 DHA/EPA: EPA and DHA are long-chain omega-3 fatty acids; DHA is an important brain membrane component. They are not a universal supplement treatment for depression or cognitive decline; clinical results vary by population and formulation. | EPA and DHA are long-chain omega-3 fatty acids; DHA is an important brain membrane component. They are not a universal supplement treatment for depression or cognitive decline; clinical results vary by population and formulation. |
Lifestyle and clinical care
- Exercise: May be an option in depression care; a particular programme is not automatically equivalent to medication or sufficient for everyone.
- Sleep: Sleep problems and mood should be assessed together; changing sleep habits alone does not guarantee treatment of depression.
- Social support: Can be considered in a care plan according to individual needs; it is not itself proof of neuroprotection or recovery.
- Light: General advice about daylight is distinct from clinical light therapy; a fixed morning duration does not establish depression benefit for everyone.
Sources
- Hausenblas HA, et al. (2013). Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. Journal of Integrative Medicine, 11(6), 377–383. PubMed · PMID 24299602
- Linde K, et al. (2008). St John's Wort for major depression. Cochrane Database of Systematic Reviews, (4). PubMed · PMID 18843608
- Sublette ME, et al. (2011). Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Journal of Clinical Psychiatry, 72(12), 1577–1584. PubMed · PMID 21939614
- Boyle NB, et al. (2017). The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients, 9(5), 429. PubMed · PMID 28445426
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
No in clinically diagnosed moderate to severe depression or anxiety disorder. Natural supports cannot replace treatment under the supervision of a psychiatrist. They may be effective alone for mild symptoms; however, it is safe to make this decision with a clinician.
L-Theanine or magnesium cannot automatically be considered safe with antidepressants. Interaction assessment depends on the medicine, product, dose and health circumstances; check with a clinician or pharmacist before adding a product. In particular, 5-HTP and St John’s wort carry serious interaction risks with serotonergic medicines.
These substances are examples studied under the same topic; their combined efficacy and safe dosing schedules have not been established. Single-substance studies do not prove clinical synergy of a combination. Review the source profiles together with interaction warnings.
No established timeframe